Literature DB >> 12394373

Rethinking growth failure in Alagille syndrome: the role of dietary intake and steatorrhea.

Alisha J Rovner1, Joan I Schall, Abbas F Jawad, David A Piccoli, Virginia A Stallings, Andrew E Mulberg, Babette S Zemel.   

Abstract

OBJECTIVE: To characterize the energy and nutrient intake, and the degree of fat malabsorption in children with Alagille syndrome (AGS) and to examine their cross-sectional associations with growth and nutritional status.
METHODS: Prepubertal children with AGS were evaluated for dietary intake, growth, bone age, and body composition. Children and their families collected a three-day, weighed diet record at home. Stools were collected for 72 hours and the coefficient of fat absorption (COA) was determined.
RESULTS: Children (mean age 6.7 +/- 3.6 years) with AGS (n = 26) had low height-for-age z-scores (HAZ), weight-for-age z-scores (WAZ) (-1.9 +/- 1.3 and -1.7 +/- 1.1, respectively), and delayed skeletal maturation (-1.4 +/- 1.8 years). Fifty-eight percent of the subjects were less than the 5th percentile for height and 54% were less than the 5th percentile for weight. At least 20% of children with AGS had low dietary intake for several nutrients including: calories, fat, calcium, vitamin D, and vitamin E. Children who consumed <2/3 Dietary Reference Intake (DRI) for calcium (n = 6) had a statistically significantly lower HAZ (-3.2 +/- 1.3) than those who consumed >2/3 DRI (-1.5 +/- 1.0), (P < 0.003). Ninety-six percent of the subjects had steatorrhea with a mean COA of 75 +/- 16%.
CONCLUSIONS: These data suggest that prepubertal children with AGS are at-risk for poor nutrient intake which, compounded with steatorrhea, may have a negative effect on growth and nutritional status. Intervention studies to increase energy and nutrient intake are needed to determine the effect of improved dietary intake on growth and nutritional status of children with AGS.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12394373     DOI: 10.1097/00005176-200210000-00007

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  7 in total

1.  Power of deep, all-exon resequencing for discovery of human trait genes.

Authors:  Gregory V Kryukov; Alexander Shpunt; John A Stamatoyannopoulos; Shamil R Sunyaev
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-06       Impact factor: 11.205

2.  Pancreatic insufficiency is not a prevalent problem in Alagille syndrome.

Authors:  Binita M Kamath; David A Piccoli; John C Magee; Ronald J Sokol
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-11       Impact factor: 2.839

3.  Bone geometry and microarchitecture deficits in children with Alagille syndrome.

Authors:  Joseph M Kindler; Ellen L Mitchell; David A Piccoli; Adda Grimberg; Mary B Leonard; Kathleen M Loomes; Babette S Zemel
Journal:  Bone       Date:  2020-08-11       Impact factor: 4.398

4.  Exocrine pancreatic function in children with Alagille syndrome.

Authors:  Dorota Gliwicz; Irena Jankowska; Aldona Wierzbicka; Anna Miśkiewicz-Chotnicka; Aleksandra Lisowska; Jarosław Walkowiak
Journal:  Sci Rep       Date:  2016-10-17       Impact factor: 4.379

5.  Outcomes of Childhood Cholestasis in Alagille Syndrome: Results of a Multicenter Observational Study.

Authors:  Binita M Kamath; Wen Ye; Nathan P Goodrich; Kathleen M Loomes; Rene Romero; James E Heubi; Daniel H Leung; Nancy B Spinner; David A Piccoli; Estella M Alonso; Stephen L Guthery; Saul J Karpen; Cara L Mack; Jean P Molleston; Karen F Murray; Philip Rosenthal; James E Squires; Jeffrey Teckman; Kasper S Wang; Richard Thompson; John C Magee; Ronald J Sokol
Journal:  Hepatol Commun       Date:  2020-01-22

Review 6.  Alagille Syndrome: Diagnostic Challenges and Advances in Management.

Authors:  Mohammed D Ayoub; Binita M Kamath
Journal:  Diagnostics (Basel)       Date:  2020-11-06

7.  Feeding practices in 6-24-month-old children with chronic cholestatic liver diseases: a mixed-method study.

Authors:  Xiao Chen; Jianshe Wang; Yi Lu; Xinbao Xie; Ying Gu; Jos M Latour; Yuxia Zhang
Journal:  BMC Pediatr       Date:  2020-08-24       Impact factor: 2.125

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.